Comparison of the Outcomes of Enhanced Recovery After Surgery and Traditional Recovery Pathway in Robotic Hysterectomy for Benign Indications: A Randomized Controlled Trial

Study Objective: The present study aimed to evaluate the impact of the implementation of the enhanced recovery after surgery (ERAS) program in patients undergoing robotic hysterectomy for benign indications in comparison with conventional management. Design: Randomized controlled trial. Setting: North Indian tertiary care hospital. Participants: Patients aged 40 to 60 years willing to sign the informed written consent were included, whereas cases with contraindications for neuraxial anesthesia were excluded. A total of 130 subjects undergoing robotic hysterectomy were divided into ERAS (n = 65) and conventional (non-ERAS) (n = 65) groups. Interventions: Components of the ERAS protocol included preoperative counseling, carbohydrate loading, early removal of catheter, and early ambulation. Both groups underwent optimization of medical conditions, standardized anesthesia, and venous thromboembolism prophylaxis. Measurements and Main Results: Outcome measures included length of hospital stay (LOHS), time to tolerance of diet, postoperative complications, readmission rates, and quality of life assessed by WHO-QOL BREF. Baseline characteristics were comparable between groups. ERAS group showed significantly lower docking time (4.82 +/- 0.73 vs 5.31 +/- 0.92 minutes), faster tolerance of diet (0.14 +/- 0.35 vs 1.14 +/- 0.35 days), and earlier resumption of ambulation (0.42 +/- 0.5 vs 1.26 +/- 0.44 days). Time for "fit for discharge" (1.43 +/- 0.61 vs 2.97 +/- 1.1 days) and LOHS (2.85 +/- 1.09 vs 3.78 +/- 1.29 days) were significantly lower in the ERAS group. Postoperative complications and readmission rates were comparable. Quality-of-life scores favored the ERAS group at postoperative days 1 and 30. Conclusion: The combination of ERAS and robotic surgery improves patient outcomes, shortens hospital stays, and enhances postoperative recovery without increasing complications. This research serves as a pioneering effort in assessing the impact of ERAS on robotic hysterectomy for benign indications, providing valuable insights for future multicentric studies and supporting the integration of ERAS protocols to enhance patient outcomes and quality of life. Journal of Minimally Invasive Gynecology (2024) 31, 601-606. (c) 2024 AAGL. All rights are reserved, including those for text and data mining, AI training, and similar technologies.